NINL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.782840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.820970E-01
Normal-vs-Stage2
3.058400E-03
Normal-vs-Stage3
1.261790E-01
Normal-vs-Stage4
5.955700E-02
Stage1-vs-Stage2
5.538800E-01
Stage1-vs-Stage3
1.095600E-01
Stage1-vs-Stage4
3.428200E-01
Stage2-vs-Stage3
1.62006999999686E-05
Stage2-vs-Stage4
3.459800E-01
Stage3-vs-Stage4
3.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.070200E-01
Normal-vs-AfricanAmerican
1.782600E-01
Normal-vs-Asian
6.657600E-02
Caucasian-vs-AfricanAmerican
9.064200E-01
Caucasian-vs-Asian
7.356200E-01
AfricanAmerican-vs-Asian
6.956400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.055400E-01
Normal-vs-Female
2.769000E-01
Male-vs-Female
6.409000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.540800E-01
Normal-vs-Age(41-60Yrs)
1.470980E-01
Normal-vs-Age(61-80Yrs)
2.303200E-01
Normal-vs-Age(81-100Yrs)
1.348210E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.085200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.119000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.725700E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.532000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.323420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.414420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.618300E-03
Normal-vs-Daily Drinker
1.618250E-02
Normal-vs-Weekly Drinker
6.258300E-02
Normal-vs-Occasional Drinker
9.740400E-01
Normal-vs-Social Drinker
4.120000E-02
Non Drinker-vs-Daily Drinker
8.465800E-01
Non Drinker-vs-Weekly Drinker
1.698250E-01
Non Drinker-vs-Occasional Drinker
1.290000E-01
Non Drinker-vs-Social Drinker
5.410000E-01
Daily Drinker-vs-Weekly Drinker
2.576200E-01
Daily Drinker-vs-Occasional Drinker
1.432440E-01
Daily Drinker-vs-Social Drinker
6.806200E-01
Weekly Drinker-vs-Occasional Drinker
2.604800E-01
Weekly Drinker-vs-Social Drinker
5.110600E-01
Occasional Drinker-vs-Social Drinker
1.828640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.643000E-01
Normal-vs-Grade 2
9.533400E-01
Normal-vs-Grade 3
9.249400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.236620E-01
Grade 1-vs-Grade 3
1.498780E-01
Grade 1-vs-Grade 4
6.643000E-01
Grade 2-vs-Grade 3
6.403600E-01
Grade 2-vs-Grade 4
9.533400E-01
Grade 3-vs-Grade 4
9.249400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.011820E-01
Normal-vs-NonDiabetic
3.041600E-01
Diabetic-vs-NonDiabetic
2.680600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.784200E-02
Normal-vs-NoPancreatitis
2.549200E-01
Pancreatitis-vs-NoPancreatitis
6.661000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.887000E-01
Normal-vs-N1
3.178300E-03
N0-vs-N1
3.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.390800E-01
Normal-vs-TP53-NonMutant
5.703400E-01
TP53-Mutant-vs-TP53-NonMutant
2.078200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
